Galmed Pharmaceuticals
GLMD
#9511
Rank
C$7.33 M
Marketcap
$11.39
Share price
21.74%
Change (1 day)
12.43%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$9.11

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$9.07. In 2022 the company made an earnings per share (EPS) of -$14.34 an increase over its 2021 EPS that were of -$26.86.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$9.11-36.48%
2022-$14.34-46.62%
2021-$26.86-2.22%
2020-$27.4739.18%
2019-$19.7470.18%
2018-$11.60-41.84%
2017-$19.94-34.23%
2016-$30.3256.84%
2015-$19.339.2%
2014-$17.70-53.43%
2013-$38.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.75-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.45-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.02-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.20-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA